VBLOC is the safe way to reduce diabetes risk through weight loss and lowering of blood pressure. Just check out the full Bloomberg story(only extract here).
Merck & Co. (MRK), Novo Nordisk A/S (NOVOB) and other makers of popular treatments for diabetes may be asked to collect more data on a potential cancer link even as they try to reassure U.S. regulators this week of the drugs’ safety.
The Food and Drug Administration said it’s considering setting up a study, either through the agency or the companies, that looks deeper into whether medicines for Type 2 diabetes, including Merck’s Januvia and Bristol Myers-Squibb Co.’s Byetta, cause pancreatic cell growth that could turn cancerous. One option is a large clinical trial designed to show patterns of adverse events, said Morgan Liscinsky, an FDA spokeswoman.
A debate swirled in the medical community in March with talk of unpublished findings that the FDA said may show pre-cancerous cellular changes in diabetics taking drugs called incretin mimetics. The FDA is reviewing the data and scientists from the agency and the companies are gathering today at the National Institutes of Health to sort it out.
“We need some calm heads and to look at the data and try and make some reasonable judgments out of this,” Robert Ratner, chief scientific and medical officer of the American Diabetes Association, said in an interview. “We are all anxious to be sure the therapies we have available are safe, but we also want to make sure we have therapies available.”